Parthenolide induces superoxide anion production by stimulating EGF receptor in MDA-MB-231 breast cancer cells

International Journal of Oncology

Volumn 43, Issue 6, 2013, Pages 1895-1900

  D'Anneo, A ^a   Carlisi, D ^a   Emanuele, S ^a   Buttitta, G ^a   Di Fiore, R ^a   Vento, R ^a,b   Tesoriere, G ^a,b   Lauricella, M ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Temple University   (United States)

Author keywords

Breast cancer cells; Epidermal growth factor receptor; NADPH oxidase; Parthenolide

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACETYLCYSTEINE; APOCYNIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROETHIDINE; PARTHENOLIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SESQUITERPENE LACTONE; SUPEROXIDE; TYROSINE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ACETOPHENONES; ACETYLCYSTEINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME INHIBITORS; FEMALE; HUMANS; NADPH OXIDASE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SESQUITERPENES; SUPEROXIDES; TYRPHOSTINS;

EID: 84891922858     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2137     Document Type: Article

References (37)

1. Ghantous A, Sinjab A, Herceg Z and Darwiche N: Parthenolide: from plant shoots to cancer roots. Drug Discov Today 18: 894-905, 2013.
2. Kim SL, Trang KT, Kim SH, Kim IH, Lee SO, Lee ST, Kim DG and Kim SW: Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis. Int J Oncol 41: 1547-1553, 2012.
3. Yip-Schneider MT, Nakshatri H, Sweeney CJ, Marshall MS, Wiebke EA and Schmidt CM: Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells. Mol Cancer Ther 4: 587-594, 2005.
4. Sun Y, St Clair DK, Xu Y, Crooks PA and St Clair WH: A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells. Cancer Res 70: 2880-2890, 2010.
5. Wang W, Adachi M, Kawamura R, Sakamoto H, Hayashi T, Ishida T, Imai K and Shinomura Y: Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity. Apoptosis 11: 2225-2235, 2006.
6. D'Anneo A, Carlisi D, Lauricella M, Emanuele S, Di Fiore R, Vento R and Tesoriere G: Parthenolide induces caspase-independent and AIF-mediated cell death in human osteosarcoma and melanoma cells. J Cell Physiol 228: 952-967, 2013.
7. D'Anneo A, Carlisi D, Lauricella M, Puleio R, Martinez R, Di Bella S, Di Marco P, Emanuele S, Di Fiore R, Guercio A, Vento R and Tesoriere G: Parthenolide generates reactive oxygen species and autophagy in MDA-MB-231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer. Cell Death Dis (In press).
8. Bazley LA and Gullick WJ: The epidermal growth factor receptor family. Endocr Relat Cancer 12: 17-27, 2005.
9. Hölsken A, Gebhardt M, Buchfelder M, Fahlbusch R, Blümcke I and Buslei R: EGFR signaling regulates tumor cell migration in craniopharyngiomas. Clin Cancer Res 17: 4367-4377, 2011.
10. Zhang J, Li H, Wang J, Dong Z, Mian S and Yu FS: Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells. Invest Ophthalmol Vis Sci 45: 2569-2576, 2004.
11. van Cruijsen H, Giaccone G and Hoekman K: Epidermal growth factor receptor and angiogenesis: opportunities for combined anticancer strategies. Int J Cancer 118: 883-888, 2006.
12. Macias A, Azavedo E, Hagerstrom T, Klintenberg C, Perez R and Skoog L: Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. Anticancer Res 7: 459-464, 1987.
13. Sequist LV, Joshi VA, Jänne PA, Muzikansky A, Fidias P, Meyerson M, Haber DA, Kucherlapati R, Johnson BE and Lynch TJ: Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing. Oncologist 12: 90-98, 2007.
14. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB and Rhee SG: Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997.
15. Cuddihy SL, Winterbourn CC and Hampton MB: Assessment of redox changes to hydrogen peroxide-sensitive proteins during EGF signaling. Antioxid Redox Signal 15: 167-174, 2011.
16. Truong TH and Carroll KS: Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation. Biochemistry 51: 9954-9965, 2012.
17. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, Symons M, Borrello S, Galeotti T and Ramponi G: Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161: 933-944, 2003.
18. Jagadeesha DK, Takapoo M, Banfi B, Bhalla RC and Miller FJ Jr: Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration. Cardiovasc Res 93: 406-413, 2012.
19. Giuliano M, Lauricella M, Calvaruso G, Carabillò M, Emanuele S, Vento R and Tesoriere G: The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells. Cancer Res 59: 5586-5595, 1999.
20. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
21. Voldborg BR, Damstrup L, Spang-Thomsen M and Poulsen HS: Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 8: 1197-1206, 1997.
22. Paletta-Silva R, Rocco-Machado N and Meyer-Fernandes JR: NADPH oxidase biology and the regulation of tyrosine kinase receptor signaling and cancer drug cytotoxicity. Int J Mol Sci 14: 3683-3704, 2013.
23. Hordijk PL: Regulation of NADPH oxidases: the role of Rac proteins. Circ Res 98: 453-462, 2006.
24. Boudreau HE, Casterline BW, Rada B, Korzeniowska A and Leto TL: Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to- mesenchymal transition and migration of breast epithelial cells. Free Radic Biol Med 53: 1489-1499, 2012.
25. Wu F, Tyml K and Wilson JX: iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells. J Cell Physiol 117: 207-214, 2008.
26. Zhua XF, Liua ZC, Xiea BF, Lia ZM, Fenga GK, Yangb D and Zeng YX: EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells. Cancer Lett 169: 27-32, 2001.
27. Schlessinger J: Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110: 669-672, 2002.
28. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T and Mitsudomi T: Mutations of epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 64: 8919-8923, 2004.
29. Rampaul RS, Pinder SE, Nicholson RI, Gullick WJ, Robertson JF and Ellis IO: Clinical value of epidermal growth factor receptor expression in primary breast cancer. Adv Anat Pathol 12: 271-273, 2005.
30. Lauricella M, Ciraolo A, Carlisi D, Vento R and Tesoriere G: SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells. Biochimie 94: 287-299, 2012.
31. Lee CS, Hall RE, Alexander IE, Koga M, Shine J and Sutherland RL: Inverse relationship between estrogen receptor and epidermal growth factor. Growth Factors 3: 97-103, 1990.
32. Gamou S and Shimizu N: Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor. FEBS Lett 357: 161-164, 1995.
33. Haj FG, Markova B, Klaman LD, Bohmer FD and Neel BG: Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 278: 739-744, 2003.
34. Chiarugi P: PTPs versus PTKs: the redox side of the coin. Free Radic Res 39: 353-364, 2005.
35. Paulsen CE, Truong TH, Garcia FJ, Homann A, Gupta V, Leonard SE and Carroll KS: Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity. Nat Chem Biol 8: 57-64, 2011.
36. Tamas P, Solti Z, Bauer P, Illes A, Sipeki S, Bauer A, Farago A, Downward J and Buday L: Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac. J Biol Chem 278: 5163-5171, 2003.
37. Sheng ZG, Huang W, Liu YX, Yuan Y and Zhu BZ: Ofloxacin induces apoptosis via β1 integrin-EGFR-Rac1-Nox2 pathway in microencapsulated chondrocytes. Toxicol Appl Pharmacol 267: 74-87, 2013.